生物素Anti-Cytokeratin 18抗体[DC-10] (ab27551)
Key features and details
- Biotin Mouse monoclonal [DC-10] to Cytokeratin 18
- Suitable for: Flow Cyt (Intra), WB
- Reacts with: Human
- Conjugation: Biotin
- Isotype: IgG1
概述
-
产品名称
生物素Anti-Cytokeratin 18抗体[DC-10]
参阅全部 Cytokeratin 18 一抗 -
描述
生物素小鼠单克隆抗体[DC-10] to Cytokeratin 18 -
宿主
Mouse -
偶联物
Biotin -
特异性
ab27551 recognises cytokeratin peptide 18 (45 kDa) in human tissue. -
经测试应用
适用于: Flow Cyt (Intra), WBmore details -
种属反应性
与反应: Human -
免疫原
Tissue, cells or virus corresponding to Human Cytokeratin 18. Human breast carcinoma cell line PMC-42
-
阳性对照
- Flow Cyt (Intra): HeLa human cervix carcinoma cell. WB: HT-29 (reducing and non-reducing conditions) cell lysate.
-
常规说明
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
性能
-
形式
Liquid -
存放说明
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Store at -20°C or -80°C. Avoid freeze / thaw cycle. -
存储溶液
pH: 7.40
Preservative: 0.097% Sodium azide
Constituent: PBS -
Concentration information loading...
-
纯度
IgG fraction -
克隆
单克隆 -
克隆编号
DC-10 -
同种型
IgG1 -
研究领域
相关产品
-
Alternative Versions
-
Isotype control
应用
The Abpromise guarantee
Abpromise™承诺保证使用ab27551于以下的经测试应用
“应用说明”部分 下显示的仅为推荐的起始稀释度;实际最佳的稀释度/浓度应由使用者检定。
应用 | Ab评论 | 说明 |
---|---|---|
Flow Cyt (Intra) |
Use a concentration of 2 - 6 µg/ml.
|
|
WB |
Use a concentration of 1 - 2 µg/ml. Predicted molecular weight: 48 kDa.
|
说明 |
---|
Flow Cyt (Intra)
Use a concentration of 2 - 6 µg/ml. |
WB
Use a concentration of 1 - 2 µg/ml. Predicted molecular weight: 48 kDa. |
靶标
-
功能
Involved in the uptake of thrombin-antithrombin complexes by hepatic cells (By similarity). When phosphorylated, plays a role in filament reorganization. Involved in the delivery of mutated CFTR to the plasma membrane. Together with KRT8, is involved in interleukin-6 (IL-6)-mediated barrier protection. -
组织特异性
Expressed in colon, placenta, liver and very weakly in exocervix. Increased expression observed in lymph nodes of breast carcinoma. -
疾病相关
Defects in KRT18 are a cause of cirrhosis (CIRRH) [MIM:215600]. -
序列相似性
Belongs to the intermediate filament family. -
翻译后修饰
Phosphorylation at Ser-34 increases during mitosis. Hyperphosphorylated at Ser-53 in diseased cirrhosis liver. Phosphorylation increases by IL-6.
Proteolytically cleaved by caspases during epithelial cell apoptosis. Cleavage occurs at Asp-238 by either caspase-3, caspase-6 or caspase-7.
O-glycosylated at multiple sites; glycans consist of single N-acetylglucosamine residues. -
细胞定位
Cytoplasm > perinuclear region. - Information by UniProt
-
数据库链接
- Entrez Gene: 3875 Human
- Omim: 148070 Human
- SwissProt: P05783 Human
- Unigene: 406013 Human
-
别名
- Cell proliferation inducing gene 46 protein antibody
- Cell proliferation inducing protein 46 antibody
- Cell proliferation-inducing gene 46 protein antibody
see all
图片
-
Flow Cytometry analysis (intracellular staining) of HeLa cells labeling Cytokeratin 18 with ab27551 and streptavidin APC at 6 µg / ml concentration (red), and blank sample (black)
-
All lanes : Biotin Anti-Cytokeratin 18 antibody [DC-10] (ab27551) at 2 µg/ml
Lane 1 : HT-29 (Human colorectal adenocarcinoma cell line) whole cell lysate (reducing conditions)
Lanes 2-3 : MOLT-4 (Human lymphoblastic leukemia cell line) whole cell lysate (reducing conditions)
Lane 4 : HT-29 (Human colorectal adenocarcinoma cell line) whole cell lysate (non-reducing conditions)
Predicted band size: 48 kDa
Observed band size: 46 kDa why is the actual band size different from the predicted?
数据表及文件
-
SDS download
-
Datasheet download
文献 (0)
ab27551 尚未被引用在任何文献中。